Compass Therapeutics Inc.

NASDAQ: CMPX · Real-Time Price · USD
2.98
0.03 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.97
-0.34%
After-hours: Aug 15, 2025, 05:01 PM EDT

Compass Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
43.48M 24.23M 34.95M 144.51M
Short-Term Investments
83.24M 128.23M 151.66M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
568K 320K 320K 320K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
6.03M 1.42M 8.18M 2.59M
Total Current Assets
132.75M 153.88M 194.79M 147.1M
Property-Plant & Equipment
7.08M 2.67M 4.53M 6.33M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
7.65M 2.99M 4.85M 6.65M
Total Assets
140.4M 156.88M 199.65M 153.76M
Account Payables
2.25M 4.09M 3.38M 867K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 1.2M 1.1M 989K
Other Current Liabilities
2.79M 2.51M 11.69M 8.78M
Total Current Liabilities
8.87M 7.8M 16.17M 10.63M
Long-Term Debt
n/a 536K 1.84M 3.05M
Other Long-Term Liabilities
1K n/a n/a n/a
Total Long-Term Liabilities
6.3M 536K 1.84M 3.05M
Total Liabilities
15.17M 8.34M 18.01M 13.68M
Total Debt
6.63M 1.73M 2.94M 4.04M
Common Stock
13K 13K 13K 10K
Retained Earnings
-364.68M -315.31M -272.81M -233.59M
Comprehensive Income
210K 37K -302K 0.00
Shareholders Equity
125.23M 148.54M 181.64M 140.08M
Total Investments
83.24M 128.23M 151.66M n/a